دورية أكاديمية

Effect of crossover from placebo to darolutamide on overall survival in men with non-metastatic prostate cancer: sensitivity analyses from the randomised phase 3 ARAMIS study

التفاصيل البيبلوغرافية
العنوان: Effect of crossover from placebo to darolutamide on overall survival in men with non-metastatic prostate cancer: sensitivity analyses from the randomised phase 3 ARAMIS study
المؤلفون: Shore, Neal D., Fizazi, Karim, Tammela, Teuvo L.J., Luz, Murilo, Salas, Manuel Philco, Ouellette, Paul, Jr., Lago, Sérgio, Bastos, Diogo Assed, Jansz, G. Kenneth, Cárcano, Flavio Mavignier, Andrade, Lívia, Pliskin, Marc, Lazaretti, Nicolas, Arruda, Larissa, Correa Ochoa, José Jaime, Kuss, Iris, Kappeler, Christian, Sarapohja, Toni, Smith, Matthew
المصدر: In European Journal of Cancer December 2023 195
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09598049
DOI:10.1016/j.ejca.2023.113342